About CellaVision AB
CellaVision AB is a global leader in digital hematology microscopy, providing advanced solutions that integrate analyzers, instruments, reagents, and specialized software to automate and standardize cell morphology analysis in clinical laboratories. Their technology is designed to enhance diagnostic accuracy and efficiency by enabling the digital analysis of blood and various body fluid samples, thereby streamlining workflows in hematology laboratories of all sizes. This innovative approach addresses the critical need for consistent and reliable cell classification, transforming what was traditionally a subjective manual process into a more objective and efficient digital workflow.
At the core of CellaVision’s offerings is the sophisticated application of artificial intelligence (AI), deep learning, and digital imaging. These AI-driven systems facilitate the pre-classification of blood cells and advanced red blood cell morphology analysis, significantly improving the speed and precision of diagnostic procedures. The company’s commitment to innovation extends to developing a comprehensive ecosystem that combines high-precision mechanics, advanced imaging solutions, and user-friendly interfaces with specialized reagents, ensuring superior analytical and diagnostic certainty for peripheral blood smears, bone marrow aspirates (with upcoming applications), and other body fluid smears.
CellaVision’s solutions are deployed in hospitals and commercial laboratories across more than 40 countries, supported by a global network of partners and market support offices. By continuously evolving intelligent microscopy, CellaVision aims to elevate healthcare by making modern diagnostics more accessible and enabling faster, more accurate patient diagnoses and treatment decisions.
Focus Areas
Business Intelligence
| Key Investors | William Demant Fonden, Grenlunden AB, SEB Funds, Christer Fåhraeus, Handelsbanken Fonder, Fjärde AP-fonden, Case Kapitalförvaltning, Nordea Funds, AMF Pension & Fonder, Amundi |
| Partnerships | Sysmex Corporation (strategic alliance extended until 2038), Beckman Coulter (distributor) |
| Acquisitions | RAL Diagnostics (2019), Triangle Imaging, Inc. (formerly Intelligent Medical Imaging Inc. - IMI) (2001), technology platform from Clear Lake Medical Foundation (2014) |
| Technology | Digital imaging, artificial intelligence, deep learning, automated microscopy, image analysis, software for remote review and server-based solutions |
| FDA Clearances | CellaVision DM96, CellaVision DM1200, CellaVision Body Fluid Application, CellaVision DC-1, and a general test for differential counts of white blood cells, characterization of red blood cell morphology, and platelet estimations cleared products (estimated) |
What Physicians Need to Know
For physicians, CellaVision's solutions offer enhanced diagnostic certainty through AI-powered pre-classification and standardized workflows, leading to more consistent and reliable results. The automation significantly improves laboratory efficiency and turnaround time, allowing for faster diagnoses and treatment decisions. The ability to remotely review and verify cell differentials facilitates collaboration and expert consultation, especially beneficial in multi-site healthcare systems. Furthermore, the comprehensive data and image archiving capabilities provide a valuable resource for patient history and comparative analysis, while the Proficiency Software supports the continuous development of laboratory staff competency.
CellaVision's solutions are designed for seamless integration into existing laboratory workflows. They offer scalable solutions adaptable to various analysis capacities and types, with a focus on centralizing data and monitoring workflow. A key strategic advantage is their extended alliance with Sysmex Corporation until 2038, which integrates CellaVision's digital morphology with Sysmex's hematology analyzers. They also have partnerships with companies like Beckman Coulter, enabling them to offer complete solutions for improved workflow efficiency in mid-size and large laboratories.
What the Web Says
CellaVision AB generally receives positive to mixed reviews, particularly for its product, CellaVision DM, which is praised for improving workflow efficiency and accuracy in hematology labs. As an employer, reviews are more varied, with some highlighting a good work-life balance and supportive colleagues, while others point to challenges with management and internal communication.
Overall: MixedStrengths
- Improved workflow efficiency and automation in labs (CellaVision DM)
- Increased accuracy and standardization of cell differentiation
- Good work-life balance reported by some employees
- Supportive and friendly colleagues
- Innovative technology in digital morphology
- Helpful customer support for product users
Limitations
- High cost of the CellaVision DM system can be a barrier for some labs
- Steep learning curve for new users of the product
- Some employees report issues with management and internal communication
- Limited career advancement opportunities mentioned in some employer reviews
- Software can be slow or experience glitches occasionally
- Integration challenges with existing lab information systems (LIS)
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News/Review Sites
Last updated: 2026-07-17
Videos
News, demos, and interviews about CellaVision AB.
Videos load interactively. If none appear, search YouTube for CellaVision AB →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]